Conclusions
Relaxin was discovered more than 50 years ago. However, only with the advent of recombinant DNA technology have sufficient amounts of human relaxin been produced and made available for in-depth biochemical characterization and pharmacological studies. These investigations have characterized the solution and stability behavior of this hormone. In particular, degradation routes and conditions for formulation as a liquid for systemic administration or gel-based formulations for local application have been established. Pharmacological studies of human relaxin have identified the involvement of relaxin in many physiological processes, ranging from collagenolysis, inhibition of myometrial contraction, enhancement of sperm motility, to its effect of the cardiovascular system leading to lowering of blood pressure. However, the differences in relaxin activities among the different animal models have led to some contradictory observations. Thus, the full elucidation of the biology of this important human hormone lags behind the understanding of its biochemical and stability behavior. Human parturition involves a temporal sequence of events and interplay between different hormones and effector molecules (Porter, 1983; Sortino et al., 1989). It is very likely that a successful clinical application of this protein will require additional knowledge of when in the parturition cycle rhR1x should be given, how often, and in what combination with other molecules that are normally produced during labor and delivery. Not until the biology of rhR1x in humans is thoroughly understood, will it be possible to design proper human clinical trials that will demonstrate the therapeutic value of this protein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Referemces
Bagna, B., Schwabe, C., and Anderson, L. L., 1991, Effect of relaxin on facilitation of parturition in beef heifers, J. Reprod. Fertil. 91:605–615.
Bell, R. J., Eddie, L. S., Lester, A. R., Wood, E. C., Johnston, P. D., and Niall, H. D., 1988, Antenatal serum levels of relaxin in patients having preterm labour, Br. Obstet. Gynecol. 95:1264–1267.
Bell, R. J., Permezel, M., MacLennan, A., Hughes, C., Healy, D., and Brennecke, S., 1993, A randomized, double blind, placebo-controlled trial of the safety of vaginal recombinant human relaxin for cervical ripening, Obstet. Gynecol. 82:328–333.
Bongers-Binder, S., Burgardt, A., Voelter, W., and Lippert, T. H., 1991, Distribution of immunoreactive relaxin in the genital tract and in the mammary gland of non-pregnant women, din. Exp. Obstet. Gynecol. 18:161–164.
Bryant-Greenwood, G. D., 1982, Relaxin as a new hormone, Endocrine Rev. 3:62–91.
Bryant-Greenwood, G. D., 1991a, The human relaxins: consensus and dissent, Mol. and Cell. Endocrinol. 79:C125–C132.
Bryant-Greenwood, G. D., 1991b, Human decidual and placental relaxins, Reprod. Fertil. Dev. 3:385–389.
Bryant-Greenwood, G. D., and Schwabe, C., 1994, Human relaxins: chemistry and biology, Endocrine Rev. 15:5–26.
Canova-Davis, E., Baldonado, I. P., and Teshima, G. M., 1990a, Characterization of chemically synthe-sized human relaxin by high-performance liquid chromatography, J. Chromatogr. 508:81–96.
Canova-Davis, E., Kessler, T. J., Lee, P.J., Fei, D. T. W., Griffin, P., Stults, J. T., Wade, J. D., and Rinderknecht, E., 1991, Use of recombinant DNA derived human relaxin to probe the structure of the native protein, Biochemistry 30:6006–6013.
Canova-Davis, E., Tishima, G. M., Kessler, T. J., Lee, P. J., Kuzzetta, A.W., and Hancock, W.S., 1990b, Strategies for an analytical examination of biological pharmaceuticals, in: Analytical Biotechnology: Capillary Electrophoresis and Chromatography (C. Horvarth and J. G. Nikelly, eds.), American Chemical Society Symposium Series 434, Washington, D. C., pp. 90–112.
Chang, C. T., Wu, C. C., and Yang, J. T., 1978, Circular dichroic analysis of protein conformation: inclusion of the B-turns, Anal. Biochem. 91:13–31.
Chen, S. A., Perlman, A. J., Spanski, N., Peterson, C. M., Sanders, S. W., Jaffe, R., Martin, M., Yalcinkaya, T., Cefalo, R. C., Chescheir, N. C., Menard, M. K., and Mordenti, J., 1993, The pharmaco-kinetics of recombinant human relaxin in non-pregnant women after intravenous, intravaginal, and intracervical administration, Pharm. Res. 10:834–838.
Chen, S. A., Reed, B., Tue. N., Gaylord, N., Fuller, G., and Mordenti, J., 1992, The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and Rhesus monkeys after intravenous and intravaginal administration, Pharm. Res. 10:223–227.
Cipolla, D. C., and Shire, S. J., 1991, Analysis of oxidized human relaxin by reverse phase HPLC, mass spectrometry and bioassays, in: Techniques in Protein Chemistry II (J. J. Villafranca, ed.), Academic Press, New York, pp. 543–555.
Cossum, P. A., Dwyer, K. A., Roth, M., Chen, S. A., Moffat, B., Vandlen, R., and Ferraiolo, B., 1992, The disposition of human relaxin (hR1x-2) in pregnant and non-pregnant rats, Pharm. Res. 9:419–424.
Du, Y.-C, Minasian, E., Tregear, G. W., and Leach, S. J., 1982, Circular dichroism studies of relaxin and insulin peptide chains, Int. J. Peptide Protein Res. 20:47–55.
Eichner, E., Herman, T., Kritzer, L., Platock, G. M., and Rubinstein, L., 1958, The effect of relaxin on term and premature labour, Ann. N.Y. Acad. Sci. 75:1023.
Eigenbrot, C., Randal. M., Quan, C., Burnier, J., O’Connell, L., Rinderknecht, E., and Kossiakoff, A. A., 1991, X-ray structure of human relaxin at 1.5 Å, J. Mol. Biol. 221:15–21.
Evans, M. I., Dougan, M.-B., Moawad, A. H., Evans, W. J., Bryant-Greenwood, G. D., and Greenwood, F. C., 1983, Ripening of the human cervix with porcine ovarian relaxin, Am. J. Obstet. Gynecol. 147:410–414.
Fei, D. T. W., Gross, M. C., Lofgren, J. L., Mora-Worms, M., and Chen, A. B., 1990, Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells—a specific and high throughput in vitro bioassay, Biochem. Biophys. Res. Commun. 170:214–222.
Ferraiolo, B. L., Cronin, M., Bakhit, C. R., M., Chesnut, M., and Lyon, R., 1989, The pharmacokinetics and pharmacodynamics of a human relaxin in the mouse pubic symphysis bioassay. Endocrinology 125:2922–2926.
Frieden, E. H., and Hisaw, F. L., 1953, Recent Progress in Hormone Research, Vol. 8 (G. Pincus, ed.), Academic Press, New York, p. 333.
Golub, M. S., Working, P. K., Cragun, J. R., Cannon, R. A., and Green, J. D., 1994, Short term infusion of recombinam human relaxin on blood pressure in the late-pregnant rhesus macaque, Obstet. Gynecol. 83:85–88.
Han, X., Habuchi, Y., and Giles, W. R., 1994, Relaxin increases heart rate by modulating calcium current in cardiac pacemaker cells, Circ. Res. 74:537–541.
Harris, M. A., Rees, J. M., Laughlin, E. A., Ford, W. C. L., Wardle, P. G., Hull, M. G. R., and Wathes, D. C., 1988, An evaluation of the role of relaxin in the penetration of cervical mucus by spermatozoa, Hum. Reprod. 3:856–860.
Hisaw, F. L., 1926, Experimental relaxation of the pubic ligament of guinea pig, Proc. Soc. Exper. Biol. Med. 23:661–663.
Hudson, P., Haley, J., John, M., Cronk, M., Crawford, R., Haralambidia, J., Tregear, G., Shine, J., and Niall, H., 1983, Structure of a genomic clone encoding biologically active human relaxin, Nature 301:928–631.
Hudson, P., John, M., Crawford, R., Haralambidis, J., Scanlon, D., Gorman, J., Tregear, G., Shine, J., and Niall, H., 1984, Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA, EMBO J. 3:2333–2339.
Hwang, J. J., Lee, A. B., Fields, P. A., Haab, E. M., Mojonier, L. E., and Sherwood, O. D., 1991, Monoclonal antibodies specific for rat relaxin V: Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts development of the mammary apparatus and, hence, lactational performance in rats, Endocrinology 129:3034–3042.
Kakouris, H., Eddie, L.W., and Summers, R., 1993, Relaxin: more than just a hormone of pregnancy, T.I.P.S. 181:1306.
Kemp, B. E. and Niall, H. D., 1984, Relaxin, Vitam. Horm. 41:79–115.
Kibblewhite, D., Larrabee Jr., W. F., and Sutton, D., 1992, The effect of relaxin on tissue expansion, Arch. Otolaryngol. Head Neck Surg. 118:153–156.
Lessing, J. B., Brenner, S. H., Schoenfield, C., Goldsmith, L. T., Amelar, R. D., Dubin, L., and Weiss, G., 1985, The effect of relaxin on the motility of sperm in freshly thawed human semen, Fertil. Steril. 44:406–409.
Li, S., Nguyen, T. H., Schoneich, C., and Borchardt, R. T., 1995, Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation, Biochemistry 34:5762–5772.
MacLennan, A. H. and Grant, P., 1991, Human relaxin—in vitro response of human and pig myemetrium, J. Reprod. Med. 36:630–634.
MacLennan, A. H., Grant, P,, Ness, D., and Down, A., 1986a, Effect of porcine relaxin and progesterone on rat, pig and human myometrial activity in vitro, J. Reprod. Med. 31:43–49.
MacLennan, A., Green, R. C., Bryant-Greenwood, G. D., Greenwood, F. C., and Seamark, R. F., 1981, Cervical ripening with combinations of vaginal prostaglandin F2a, estradiol and relaxin, Obstet. Gynecol. 58:601–604.
MacLennan, A. H., Green, R. C., Grant, P., and Nicolson, R., 1986b, Ripening of the human cervix and induction of labor with intracervical purified porcine relaxin, Obstet. Gynec. 68:598–601.
Musah, A. I., Schwabe, C., Wilham, R. L., and Anderson, L. L., 1986, Pelvic development as affected by relaxin in three genetically electedframe sizes of beef heifers, Endocrinology 34:363–369.
Neuwinger, J., Jockenhovel, F., and Nieschlay, E., 1990, The influence of relaxin on motility of human sperm in vitro, Andrologia 22:335–339.
Nguyen, T. H., Burnier, J., and Meng, W., 1993, The kinetics of relaxin oxidation by hydrogen peroxide, Pharm. Res. 10:1563–1571.
Norstrom, A., Bryman, I., Wiquist, N., Sahni, S., and Lindblom, B., 1984, Inhibiting action of relaxin on human cervical smooth muscle, J. Clin. Endocrinol. Metab. 59:379–382.
Osheroff, P. L., and Phillips, H. S., 1991, Autoradiographic localization of relaxin binding sites in rat brain, Proc. Natl. Acad. Sci. 88:6413–6417.
Peterson, L. K., Skajaa, K., and Uldbjerg, N., 1992, Serum relaxin as a potential marker for preterm labour, Br. J. Obstet. Gynecol. 99:292–295.
Porter, D. G., 1983, The possible involvement of relaxin in the regulation of uterine contraction, in: Biology of Relaxin and Its Role in the Human (M. Bigazzi, F. C. Greenwood, and F. Gasparri, eds.), Excerpta Medica, Princeton, NJ, pp. 114–124.
Provencher, S. W., and Glockner, J., 1981, Estimation of globular protein secondary structure from circular dichroism, Biochemistry 20:33–37.
Rawitch, A. B., Moore, W. V., and Frieden, E. H., 1980, Relaxin-insulin homology: predictions of secondary structure and lack of competitive binding, Int. J. Biochem. 11:357–362.
Schwabe, C., and Harmon, S. J., 1978, A comparative circular dichroism study of relaxin and insulin, BBRC 84:374–380.
Sherwood, O. D., 1988, Relaxin, in: The Physiology of Reproduction (E. Knobil and J. Neill, eds.), Raven Press, New York, pp. 585–673.
Sherwood, O. D., 1993, Relaxin, in: The Physiology of Reproduction (E. Knobil and J. Neill, eds.), Raven Press, New York, pp. 861–1009.
Sherwood, O. D., Downing, S. J., Guico-Lamm, M. L., Hwang, J. J., O’Day-Bowman, M. B., and Fields, P. A., 1993, The phsiological effects of relaxin during pregnancy: studies in rats and pigs, Oxford Rev. Reprod. Biol. 15:143–189.
Shire, S. J., Holladay, L. A., and Rinderknecht, E., 1991, Self-association of human and porcine relaxin as assessed by analytical ultracentrifugation and circular dichroism, Biochemistry 30:7703–7711.
Sortino, M. A., Cronin, M. J., and Wise, P. M., 1989, Relaxin stimulates prolactin secretion from anterior pituitary cells, Endocrinology 124:2013–2015.
Steinetz, B. G., Beach, V. L., and Kroc, R. L., 1969, Bioassay of relaxin, in: Methods in Hormone Research, 2nd ed. (R. I. Dorfman, ed.), Academic Press, New York, pp. 481–513.
Steinetz, B. G., O’Byrne, E. M, Butler, M. C., and Hickman, L. B., 1982, Hormonal regulation of the connective tissue of the symphysis pubis, in: Biology of Relaxin and Its Role in the Human (M. Bigazzi, F. C. Greenwood, and F. Gaspari, eds.), Excerpta Medica, Princeton, NJ, p. 71.
Stults, J. T, Bourell, J. H., Canova-Davis, E., Ling, V. T., Laramee, G. R., Winslow, J. W., Griffin, P. R., Rinderknecht, E., and Vandlen, R. L., 1990, Structural characterization by mass spectrometry of native and recombinant human relaxin, Biomed. Environ. Mass Spectrom. 19:655–664.
Unemori, E. L., and Amento, E. P., 1990, Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts, J. Biol. Chem. 265:337–342.
Unemori, E. L., Bauer, E. A., and Amento, E. P., 1992, Relaxin alone and in conjunction with interferongamma decreases collagen synthesis by cultured human scleroderma fibroblasts, J. Invest. Dermatol. 99:337–342.
Unemori, E. N., Beck, S. L., Lee, W. P., Xu, Y., Siegel, M., Keller, G., Liggit, H. D., Bauer, E. A., and Amento, E. P., 1993, Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis, J. Invest. Dermatol. 101:280–285.
Ward, D. G., Thomas, G. R., and Cronin, M. J., 1992, Relaxin increases rat heart rate by a direct action on the cardiac atrium, Biochem. Biophys. Res. Commun. 186:999–1005.
Weiss, G., 1989, Relaxin in the male, Biol. Reprod. 40:197–200.
Winslow, J. W., Shih, A., Bourell, J. H., Weiss, G., Reed, B., Stults, J. T., and Goldsmith, L. T., 1992, Human seminal relaxin is the same product gene as human luteal relaxin, Endocrinology 130:2660–2668.
Wood, S. P.. Blundell, T. L., Lazarus, N. R, and Neville, W. J., 1975, The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins, Eur. J. Biochem. 55:531–542.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Nguyen, T.H., Shire, S.J. (2002). Stability and Characterization of Recombinant Human Relaxin. In: Pearlman, R., Wang, Y.J. (eds) Formulation, Characterization, and Stability of Protein Drugs: Case Histories. Pharmaceutical Biotechnology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/0-306-47452-2_5
Download citation
DOI: https://doi.org/10.1007/0-306-47452-2_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45332-8
Online ISBN: 978-0-306-47452-1
eBook Packages: Springer Book Archive